Cero Therapeutics Holdings, Inc. (CERO): R&D Expense
Older than the company's other figures. The latest R&D Expense is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$5.29M
Year ended 2023-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $5.29M | n/a | 2025-04-15, From 2023-01-01 |